跳至主要内容
临床试验/NCT07253051
NCT07253051招募中不适用

BRCA Mutation Carriers' Platform, a Multicenter Study

Fondazione Policlinico Universitario Agostino Gemelli IRCCS39 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2025年4月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10,000
试验地点
39
主要终点
Collection data about BRCA mutation

研究概览

简要总结

Subjects who carry mutations in breast cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2 genes) are at higher risk of developing cancers. Despite the cumulative amount of evidence published in the literature in the last two decades, the management of BRCA mutation carriers is still not completely defined.

Since the prevalence of the mutation is estimated to be 1:400 - 1:500 individuals, the total number of BRCA mutation carriers should be around 140.000 - 150.000 in the Italian population. It is estimated that 87% of women with BRCA mutations will experience, in their lifetime, a tumor with a genetic origin. About 20% of the 5200 ovarian cancer cases diagnosed each year in Italy has a genetic origin and could potentially be the object of primary prevention. To date, and to the best of our knowledge, a national prospective data collection on women with BRCA mutations has not been yet established.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •All women who are 18 years of age or older;
  • •All women who known to be carriers of a pathogenetic mutation class 4 and 5 of the International Agency of Research on Cancer classification) of the BRCA1 or BRCA2 genes.

排除标准

  • •Age < 18 years old;
  • •No pathogenetic mutation carriers.

结局指标

主要结局

Collection data about BRCA mutation

时间窗: 1 day

To collect data of each female individual carrying a BRCA1 or BRCA2 mutation

次要结局

  • GEOGRAPHICAL DISTRIBUTION OF BRCA MUTATIONS(6 months)
  • CENTRALIZATION OF CASES IN HIGHLY SPECIALIZED CENTERS(6 months)
  • RELATIONSHIP BETWEEN SPECIFIC MUTATIONS AND SPECIFIC TYPES OF CANCER(6 months)
  • CRITERIA FOR DETERMINING THE ACCESS TO GENETIC EVALUATION(6 months)
  • LIFESTYLE RISK FACTORS(6 months)
  • DEFINITION OF PREVENTIVE STRATEGIES(6 months)
  • Risk-reducing salpingo-oophorectomy(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (39)

Loading locations...

相似试验